MPT: Novel Drug Reverses Anticoagulation in Emergencies

ACC Conference Reporter

ACC.18 | ORLANDO, FL — Patients on anticoagulants such as apixaban (Eliquis) who develop bleeding emergencies may be able to reverse the drug's impact with the investigational agent andexanet, researchers said here. Read More >>>

Keywords: ACC18, ACC Annual Scientific Session

< Back to Listings